Skip to content

Indirect vs. Direct Decompression for Treatment of Central Stenosis: RCT

Is Indirect Decompression Sufficient for the Treatment of Central Stenosis?: A Randomized Controlled Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04708977
Acronym
IDVD
Enrollment
0
Registered
2021-01-14
Start date
2021-02-08
Completion date
2021-09-29
Last updated
2021-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Spinal Stenosis Indicated for LLIF

Keywords

Lateral Lumbar Interbody Fusion (LLIF), Foraminal Stenosis, Spine Fusion, Decompression, Lumbar

Brief summary

This is a prospective, randomized clinical trial of patients undergoing 1-level lateral lumbar spinal fusion. This study seeks to randomize patients indicated for Lateral Lumbar Interbody Fusion (LLIF) into one of two groups: direct decompression and indirect decompression.

Detailed description

While indirect decompression has been largely accepted as a strategy to treat foraminal stenosis, there is some disagreement regarding its efficacy in treating patients with central and lateral recess stenosis. The current study seeks to randomize patients indicated for Lateral Lumbar Interbody Fusion (LLIF) into one of two groups: direct decompression and indirect decompression. Enrolled participants will be evaluated before surgery, during their hospital course and post-operatively at 6 weeks, 3 months, 6 months, 1 and 2 years. Operative details, complications, reoperation rates, patient reported outcomes, clinical and radiographic outcome measures will be compared.

Interventions

PROCEDUREOne-level lateral lumbar interbody fusion with Indirect Decompression

One-level lateral lumbar interbody fusion, with or without percutaneous posterior instrumentation. Thorough discectomy will be performed using lateral access. Fusion will then be performed using lateral access interbody cage and allograft bone graft with or without use of recombinant human bone morphogenic protein 2.

PROCEDUREOne-level lateral lumbar interbody fusion with Direct Decompression

One-level lateral lumbar interbody fusion, with or without percutaneous posterior instrumentation. Thorough discectomy will be performed using lateral access instruments. Fusion will then be performed using lateral access interbody cage and allograft bone graft with or without use of recombinant human bone morphogenic protein 2. Additionally, direct decompression through midline or parasagittal approach will be utilized. A unilateral laminotomy or complete bilateral laminectomy may be performed.

Sponsors

Hospital for Special Surgery, New York
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Patients will be blinded to randomization and surgical technique will not be evident based on postoperative radiographs. Research coordinators, surgeons, principal investigator (assisting with randomization) and other co-investigators will not be blinded to the type of surgical procedure performed.

Intervention model description

This is a single-center, prospective, randomized controlled trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Fusion indicated by the treating surgeon. Fusion may be indicated for one or more of the following reasons: * Mobile degenerative spondylolisthesis * Severe vertical foraminal stenosis * Adjacent segment degeneration and/or degenerative disc disease with suspected discogenic pain * One-level central canal stenosis * WITH neurogenic claudication * As measured in preoperative MRI * Oswestry Low Back Pain Disability Questionnaire score \> 35% (18/50) * Failed 3 months of conservative treatment * Willing to give written informed consent and psychosocially, mentally, and physically able to comply fully with protocol, including adhering to follow-up schedule and requirements, and filling out forms

Exclusion criteria

* Multilevel central canal stenosis * Patients with vertebral endplate dimensions that are too small to allow for safe placement of an intervertebral cage * Known allergy to titanium, polyethylene, cobalt, chromium, or molybdenum * Prior surgery at index disc level (discectomy, decompression, or fusion) * History of spinal or vertebral infection of the lumbar spine * History of vertebral fracture of the lumbar spine * Current pregnancy or interest in becoming pregnant over the next 1 year * Active infection-systemic or local * Non-English speakers

Design outcomes

Primary

MeasureTime frameDescription
Oswestry Disability Index (ODI)Up to 12 months post-operativelyChange in Oswestry Disability Index (ODI) 100 point scale. The Oswestry Disability Index (also known as the Oswestry Low Back Pain Disability Questionnaire) is an extremely important tool that researchers and disability evaluators use to measure a patient's permanent functional disability. The test is considered the 'gold standard' of low back functional outcome tools \[1\]. For each section the total possible score is 5: if the first statement is marked the section score = 0; if the last statement is marked, it = 5. If all 10 sections are completed the score is calculated by adding all scores for each statement, divided by 50 total possible points, and then multiplied by 100 for a percentage. Percentage scores are interpreted on a scale from 0-20% as minimal disability to 61-100% as crippled.
Comparison of Oswestry Disability Index (ODI)Up to 24 months post-operatively. (6 weeks, 3, 6, 12, and 24 months timepoints)Compare ODI scores to assess the kinetics of improvement in the control (direct decompression) vs. treatment (indirect decompression) groups. The Oswestry Disability Index (also known as the Oswestry Low Back Pain Disability Questionnaire) is an extremely important tool that researchers and disability evaluators use to measure a patient's permanent functional disability. The test is considered the 'gold standard' of low back functional outcome tools \[1\]. For each section the total possible score is 5: if the first statement is marked the section score = 0; if the last statement is marked, it = 5. If all 10 sections are completed the score is calculated by adding all scores for each statement, divided by 50 total possible points, and then multiplied by 100 for a percentage. Percentage scores are interpreted on a scale from 0-20% as minimal disability to 61-100% as crippled.

Secondary

MeasureTime frameDescription
Numeric Rated Scale (NRS)-Back and Leg pain6- Weeks, 3-, 6-, 12-, and 24-Months.Patient Reported Outcomes: Numeric Rated Scale (NRS)-back and leg pain scores
Radiographic Measurements - Lumbar LordosisPreoperative and 12-Month radiographsRadiographic measurements at 12 months will be compared to preoperative measurements to quantify the change in lumbar lordosis as a result of Lateral Lumbar Interbody Fusion (LLIF). Measurements will be taken in millimeters by (2) co-investigators.
Reoperation RateWithin 12 months and 24 months, post-operatively.Reoperation rate on the lumbar spine within 12 months and within 24 months
Radiographic Measurements - Disc Space HeightPreoperative and 12-Month radiographsRadiographic measurements at 12 months will be compared to preoperative measurements to quantify the change in disc space height as a result of Lateral Lumbar Interbody Fusion (LLIF). Measurements will be taken in millimeters by (2) co-investigators.
Radiographic Measurements - Segmental LordosisPreoperative and 12-Month radiographsRadiographic measurements at 12 months will be compared to preoperative measurements to quantify the change in segmental lordosis as a result of Lateral Lumbar Interbody Fusion (LLIF). Measurements will be taken in millimeters by (2) co-investigators.
Complication RateWithin 12 months and 24 months, post-operatively.Complication rate within 12 months and within 24 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026